167 related articles for article (PubMed ID: 1596688)
1. Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.
Doble A; Girdlestone D; Piot O; Allam D; Betschart J; Boireau A; Dupuy A; Guérémy C; Ménager J; Zundel JL
Br J Pharmacol; 1992 Jan; 105(1):27-36. PubMed ID: 1596688
[TBL] [Abstract][Full Text] [Related]
2. Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists.
Malleron JL; Comte MT; Gueremy C; Peyronel JF; Truchon A; Blanchard JC; Doble A; Piot O; Zundel JL; Huon C
J Med Chem; 1991 Aug; 34(8):2477-83. PubMed ID: 1908521
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. In vitro and ex vivo selectivity profile.
Malgouris C; Flamand F; Doble A
Eur J Pharmacol; 1993 Mar; 233(1):29-35. PubMed ID: 8386088
[TBL] [Abstract][Full Text] [Related]
4. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
5. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist.
Blackburn TP; Cox B; Thornber CW; Pearce RJ
Eur J Pharmacol; 1990 May; 180(2-3):229-37. PubMed ID: 2163866
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
[TBL] [Abstract][Full Text] [Related]
9. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'-oxoethyl)- piperidine HBr], a sigma and 5-hydroxytryptamine2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles.
Tam SW; Steinfels GF; Gilligan PJ; Schmidt WK; Cook L
J Pharmacol Exp Ther; 1992 Dec; 263(3):1167-74. PubMed ID: 1361572
[TBL] [Abstract][Full Text] [Related]
10. The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic-induced inhibition in the rat prefrontal cortex.
Godbout R; Mantz J; Glowinski J; Thierry AM
Eur J Pharmacol; 1991 Oct; 204(1):97-100. PubMed ID: 1666564
[TBL] [Abstract][Full Text] [Related]
11. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
12. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.
Stutzmann JM; Eon B; Lucas M; Blanchard JC; Laduron PM
Sleep; 1992 Apr; 15(2):119-24. PubMed ID: 1579785
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI.
Garratt JC; Kidd EJ; Wright IK; Marsden CA
Eur J Pharmacol; 1991 Jul; 199(3):349-55. PubMed ID: 1915582
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain.
Malgouris C; Flamand F; Doble A
Eur J Pharmacol; 1993 Mar; 233(1):37-45. PubMed ID: 8472747
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
Rinaldi-Carmona M; Congy C; Santucci V; Simiand J; Gautret B; Neliat G; Labeeuw B; Le Fur G; Soubrie P; Breliere JC
J Pharmacol Exp Ther; 1992 Aug; 262(2):759-68. PubMed ID: 1501121
[TBL] [Abstract][Full Text] [Related]
17. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
Arnt J; Hyttel J; Larsen JJ
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
[TBL] [Abstract][Full Text] [Related]
18. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
Skarsfeldt T; Arnt J; Hyttel J
Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
[TBL] [Abstract][Full Text] [Related]
19. The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies.
Cunningham KA; Lakoski JM
Neuropsychopharmacology; 1990 Feb; 3(1):41-50. PubMed ID: 2137698
[TBL] [Abstract][Full Text] [Related]
20. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
